{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:13:50Z","timestamp":1789704830009,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd001511.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000}}],"reference-count":154,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001511.pub3","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T22:21:25Z","timestamp":1509661285000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Glucocorticosteroids for people with alcoholic hepatitis"],"prefix":"10.1002","author":[{"given":"Chavdar S","family":"Pavlov","sequence":"first","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"},{"name":"I.M. Sechenov First Moscow State Medical University; Clinic of Internal Diseases Propedeutics; Pogodinskaja 1\/1 Moscow Russian Federation 119991"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria L","family":"Varganova","sequence":"additional","affiliation":[{"name":"Ulyanovsk Regional Clinical Hospital; Department of Gastroenterology; International 3 Ulyanovsk Russian Federation 432063"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Casazza","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"},{"name":"Universit\u00e0 degli Studi di Milano; Dipartimento di Scienze Biomediche e Cliniche \"L. Sacco\"; via GB Grassi 74 Milan Italy 20157"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street London UK NW3 2QG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrinka","family":"Nikolova","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD001511.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01072499","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study","volume":"22","author":"Blitzer","year":"1977","journal-title":"Digestive Diseases"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0002|cit2","first-page":"880","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study","volume":"64","author":"Blitzer","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0003|cit3","first-page":"769","article-title":"Prednisolone treatment of alcoholic hepatitis: forty-five patients","volume":"16","author":"Bories","year":"1987","journal-title":"La Presse Medicale"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-79-5-625","article-title":"Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial","volume":"79","author":"Campra","year":"1973","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0007|cit5","unstructured":"Erratum: Methylprednisolone therapy in patients with severe alcoholic hepatitis: Randomized multicenter trial (American Journal of Gastroenterology, Vol. 85, No. 4 (473)) American Journal of Gastroenterology 1990 776"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001511.pub3-BIB0006|cit7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840120331","article-title":"Corticosteroid therapy of alcoholic hepatitis: how many studies will it take?","volume":"12","author":"Carithers","year":"1990","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0008|cit8","first-page":"1202","article-title":"Prednisolone therapy in patients with severe alcoholic hepatitis: results of a multicenter trial","volume":"6","author":"Maddrey","year":"1986","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4103\/2141-9248.141562","article-title":"Pentoxifylline plus prednisolone versus pentoxifylline only for severe alcoholic hepatitis: a randomised controlled clinical trial","volume":"4","author":"De","year":"2014","journal-title":"Annals of Medical and Health Sciences Research"},{"issue":"3","key":"10.1002\/14651858.CD001511.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD001511.pub3-BIB0011|cit11","first-page":"A150","article-title":"Double-blind controlled trial of corticosteroid-therapy in severe alcoholic hepatitis with encephalopathy","volume":"26","author":"Depew","year":"1978","journal-title":"Clinical Research"},{"issue":"3","key":"10.1002\/14651858.CD001511.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-74-3-311","article-title":"Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy","volume":"74","author":"Helman","year":"1971","journal-title":"Annals of Internal Medicine"},{"issue":"5 II","key":"10.1002\/14651858.CD001511.pub3-BIB0014|cit13","first-page":"A","article-title":"Corticosteroid treatment of alcoholic liver disease: a controlled trial","volume":"72","author":"Maddrey","year":"1977","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD001511.pub3-BIB0013|cit14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0015|cit15","first-page":"1100","article-title":"Risk factors and therapy in alcoholic hepatitis (AH)","volume":"72","author":"Mendenhall","year":"1977","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0016|cit16","first-page":"850","article-title":"Survival after steroid treatment (T) for alcoholic hepatitis (AH)","volume":"3","author":"Mendenhall","year":"1983","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"23","key":"10.1002\/14651858.CD001511.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001511.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1530-0277.1995.tb01560.x","article-title":"Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies","volume":"19","author":"Mendenhall","year":"1995","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"24","key":"10.1002\/14651858.CD001511.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197106172842404","article-title":"Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial","volume":"284","author":"Porter","year":"1971","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0020|cit20","first-page":"319A","article-title":"Long term survival and prognostic factors in patients with severe biopsy-proved alcoholic hepatitis (AH) treated by prednisolone: randomized trial, new cohort and simulation","volume":"20","author":"Mathurin","year":"1994","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"10.1002\/14651858.CD001511.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD001511.pub3-BIB0022|cit22","first-page":"1219","article-title":"Steroids in alcoholic hepatitis: another salvo of data","volume":"87","author":"Ramond","year":"1992","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001511.pub3-BIB0023|cit23","first-page":"36","article-title":"Prednisolone for severe alcoholic hepatitis","volume":"117","author":"Ramond","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD001511.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001511.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/0168-8278(91)91241-8","article-title":"Prednisolone markedly improves short-term survival of patients with severe biopsy-proven alcoholic hepatitis A double blind randomized bicenter trial","volume":"13","author":"Ramond","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0026|cit26","first-page":"234A","article-title":"Corticosteroids (Cs) does not influence plasma tumor necrosis factor-alpha (pTNF) and interleukin 6 (pIL6) concentrations in severe alcoholic hepatitis (AH): a cross over study","volume":"16","author":"Mal","year":"1992","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0027|cit27","first-page":"S75","article-title":"Influence of corticosteroids (CS) on plasma cytokines concentrations in patients with severe alcoholic hepatitis (HA): results of a randomized study","volume":"18","author":"Richardet","year":"1993","journal-title":"Journal of Hepatology"},{"issue":"2 (Pt 1)","key":"10.1002\/14651858.CD001511.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0016-5085(78)90814-4","article-title":"Steroid treatment of alcoholic hepatitis. The yeas and the nays","volume":"74","author":"Conn","year":"1978","journal-title":"Gastroenterology"},{"issue":"28","key":"10.1002\/14651858.CD001511.pub3-BIB0029|cit29","first-page":"1050","article-title":"Alcoholic liver disease, new aspects of an old problem","volume":"108","author":"Galambos","year":"1978","journal-title":"Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0030|cit30","first-page":"443","article-title":"A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients","volume":"69","author":"Shumaker","year":"1978","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.23.1.75","article-title":"Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis","volume":"23","author":"Theodossi","year":"1982","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1745-6215-14-262","article-title":"Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial","volume":"14","author":"Forrest","year":"2013","journal-title":"Trials"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001511.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"A262","DOI":"10.1136\/gutjnl-2015-309861.562","article-title":"The liver biopsy in alcoholic hepatitis: data from the steroids or pentoxifylline in alcoholic hepatitis (STOPAH) clinical trial","volume":"64","author":"Petts","year":"2015","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001511.pub3-BIB0034|cit34","first-page":"S23","article-title":"The liver biopsy in alcoholic hepatitis: data from the steroids or pentoxifylline in alcoholic hepatitis (STOPAH) clinical trial","volume":"237","author":"Petts","year":"2015","journal-title":"Journal of Pathology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001511.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S776","DOI":"10.1016\/S0168-8278(15)31332-5","article-title":"Utility of liver biopsy in alcoholic hepatitis: data from the steroids or pentoxyfilline in alcoholic hepatitis (STOPAH) clinical trial","volume":"62","author":"Petts","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"102","key":"10.1002\/14651858.CD001511.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta191020","article-title":"The clinical effectiveness and cost-effectiveness of steroids or pentoxifylline for alcoholic hepatitis (STOPAH): a 2 x 2 factorial randomised controlled trial","volume":"19","author":"Thursz","year":"2015","journal-title":"Health Technology Assessment"},{"issue":"17","key":"10.1002\/14651858.CD001511.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/00042737-200412000-00023","article-title":"Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study","volume":"16","author":"Alvarez","year":"2004","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabr\u00e9","year":"2000","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"A868","DOI":"10.1016\/S0016-5085(98)83537-3","article-title":"Treatment of severe alcoholic hepatitis with steroids or total enteral nutrition: interim results of a prospective, randomized, multicentric trial","volume":"114","author":"Cabr\u00e9","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0041|cit41","first-page":"S5","article-title":"Short and long-term outcome in severe alcoholic hepatitis (SAH) treated with steroids or total enteral nutrition (TEN). A multicentric randomized controlled trial by the Spanish Group for the Study of Alcoholic Hepatitis","volume":"24","author":"Gassull","year":"2000","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0016-5085(12)63660-9","article-title":"Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone","volume":"81","author":"Christensen","year":"1981","journal-title":"Gastroenterology"},{"issue":"586","key":"10.1002\/14651858.CD001511.pub3-BIB0043|cit43","first-page":"119","article-title":"Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases","volume":"1","author":"Copenhagen Study Group for Liver Diseases","year":"1969","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0044|cit44","first-page":"223","article-title":"Steroid therapy in acute alcoholic hepatitis: a pooled estimate based on published randomized controlled trials","volume":"51","author":"Daures","year":"1991","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S213-S424","DOI":"10.1016\/S0168-8278(16)00210-5","article-title":"Infection is common in patients with severe alcoholic hepatitis treated with steroids but not associated with poor outcome","volume":"64","author":"Dhanda","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4684-4661-6_11","article-title":"Use of colchicine and steroids in the treatment of alcoholic liver disease","volume":"2","author":"Galambos","year":"1984","journal-title":"Recent Developments in Alcoholism"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0047|cit47","first-page":"2894","article-title":"Severe alcoholic hepatitis improved by combined treatment with prednisolone, testosterone and an amino acid supplement","volume":"4","author":"Gill","year":"1984","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0048|cit48","unstructured":"Goldis A Matei R Vernic C Strain R Treatment of acute alcoholic hepatitis with glucocorticosteroids-prognostic factors. Steatohepatitis (NASH and ASH) Falk Symposium 121 Den Haag (Netherlands) 2000 25"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0049|cit49","first-page":"81","article-title":"A controlled clinical trial of methylprednisolone in patients with the cholestatic form of alcoholic liver cirrhosis","volume":"50","author":"Hozo","year":"1996","journal-title":"Medicinski Arhiv"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0050|cit50","first-page":"137","article-title":"Controlled clinical trial of methylprednisolone in patients with the cholestatic form of alcoholic liver cirrhosis","volume":"10","author":"Hozo","year":"1997","journal-title":"Gastroenterology International"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials","volume":"113","author":"Imperiale","year":"1990","journal-title":"Annals of Internal Medicine"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD001511.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD001511.pub3-BIB0053|cit53","first-page":"232A","article-title":"In severe alcoholic hepatitis (AH) plasma tumor necrosis factor (pTNF) is inconstantly elevated and is not influenced by corticosteroid (Cs) therapy","volume":"14","author":"Mal","year":"1991","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0054|cit54","first-page":"856","article-title":"Alcoholic hepatitis","volume-title":"Diseases of the Liver","volume":"2","author":"Mendenhall","year":"1993"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"903-10","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001511.pub3-BIB0056|cit56","first-page":"269A","article-title":"Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial","volume":"60","author":"Moreno","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00042737-200507000-00011","article-title":"Bilirubin response to corticosteroids in severe alcoholic hepatitis","volume":"17","author":"Morris","year":"2005","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD001511.pub3-BIB0058|cit58","first-page":"S8","article-title":"Pilot study of granulocytapheresis and leukocytapheresis for the treatment of severe alcoholic hepatitis","volume":"8","author":"Naganuma","year":"2014","journal-title":"Hepatology International"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0060|cit60","first-page":"250A","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis: a randomized trial","volume":"34","author":"Philips","year":"2001","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0061|cit61","first-page":"234A","article-title":"Corticosteroids reduce mortality from alcoholic hepatitis in patients without encephalopathy. A meta-analysis of the randomized trials (RCTs) including French trials","volume":"14","author":"Poynard","year":"1991","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0062|cit62","first-page":"208","article-title":"Treatment of acute alcoholic hepatitis","volume":"2","author":"Reynolds","year":"1989","journal-title":"Gastroenterology International"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00365521.1976.12097111","article-title":"Alcoholic hepatitis superimposed on cirrhosis. Clinical significance and effect of long-term prednisone treatment","volume":"11","author":"Schlichting","year":"1976","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with anti-TNFa (INFLIXIMAB) or placebo in severe alcoholic hepatitis: early changes in ICAM-1, histology and biochemical parameters. A pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001511.pub3-BIB0065|cit65","first-page":"42","article-title":"A trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"36","author":"Stewart","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0066|cit66","first-page":"565","article-title":"Randomised clinical trials in hepatology","volume":"20","author":"Tygstrup","year":"1979","journal-title":"Internist"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001511.pub3-BIB0067|cit67","first-page":"424","article-title":"Systematic review: steroid, pentoxifylline or combined therapy for acute alcoholic hepatitis","volume":"10","author":"Lee","year":"2016","journal-title":"Hepatology International"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.510230513","article-title":"Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study","volume":"23","author":"Becker","year":"1996","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bmj.2.5260.1113","article-title":"Acute alcoholic hepatitis","volume":"2","author":"Beckett","year":"1961","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial Sequential Analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive--Trial Sequential Analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD001511.pub3-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011646.pub2","article-title":"Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)","author":"Buzzetti","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"21-4","DOI":"10.1002\/cpt.536","article-title":"Comment on: \u201cCell therapy for heart disease: Trial Sequential Analyses of two Cochrane Reviews\u201d","volume":"102","author":"Castellini","year":"2017","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables [see comments]","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"issue":"3065","key":"10.1002\/14651858.CD001511.pub3-BIB0078|cit78","first-page":"66","article-title":"Glucocorticosteroids are not effective in alcoholic hepatitis","volume":"94(10)","author":"Christensen","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0079|cit79","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD001511.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001511.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"2747-56","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"353-8","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"399-420","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL Clinical Practical Guidelines: management of alcoholic liver disease","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD001511.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011598.pub2","article-title":"Nutrition support in hospitalised adults at nutritional risk","author":"Feinberg","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2307\/2340521","article-title":"On the interpretation of X^2 from contingency tables, and the calculation of P","volume":"85","author":"Fisher","year":"1922","journal-title":"Journal of the Royal Statistical Society"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1174-9","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejim.2016.03.020","article-title":"Evidence-based clinical practice: overview of threats to the validity of evidence and how to minimise them","volume":"32","author":"Garattini","year":"2016","journal-title":"European Journal of Internernal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(73)80095-2","article-title":"Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance","volume":"64","author":"Gerber","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0092|cit92","unstructured":"Gluud C Nikolova D Klingenberg SL Cochrane Hepato-Biliary Group About Cochrane (Cochrane Review Groups (CRGs)) 2017, Issue 2. Art. No.: LIVER 2017"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0093|cit93","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD001511.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD001511.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD001511.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD001511.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD001511.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD001511.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD001511.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD001511.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0105|cit105","first-page":"Epub ahead of p","article-title":"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"May 18","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"20","key":"10.1002\/14651858.CD001511.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001511.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0108|cit108","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0109|cit109","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0110|cit110","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001511.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01925.x","article-title":"Discovery of the hepatitis C virus","volume":"29","author":"Houghton","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0112|cit112","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"19","key":"10.1002\/14651858.CD001511.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.1840200440","article-title":"The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey)","volume":"20","author":"Jensen","year":"1994","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"11","key":"10.1002\/14651858.CD001511.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cld.2004.11.001","article-title":"Morphology of alcoholic liver disease","volume":"9","author":"Lefkowitch","year":"2005","journal-title":"Clinics in Liver Disease"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0168-8278(99)80274-8","article-title":"Role of S-adenosyl-L-methionine in the treatment of liver diseases","volume":"30","author":"Lieber","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD001511.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD001511.pub3-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001511.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"issue":"9128","key":"10.1002\/14651858.CD001511.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD001511.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"736-42; quiz 74","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0124|cit124","unstructured":"Nordic Trial Alliance Working Group on Transparency and Registration Transparency and registration in clinical research in the Nordic countries (Report) nta.nordforsk.org\/projects\/nta_transparency_report.pdf"},{"issue":"41","key":"10.1002\/14651858.CD001511.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"784-90","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis - a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"British Journal of Surgery"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003045.pub2","article-title":"Anabolic-androgenic steroids for alcoholic liver disease","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD001511.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis -- a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0130|cit130","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"16","key":"10.1002\/14651858.CD001511.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane Reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/sim.2971","article-title":"Arcsine test for publication bias in meta-analyses with binary outcomes","volume":"27","author":"R\u00fccker","year":"2008","journal-title":"Statistics in Medicine"},{"issue":"35","key":"10.1002\/14651858.CD001511.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD001511.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD001511.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0168-8278(01)00190-8","article-title":"Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood","volume":"35","author":"Spahr","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0139|cit139","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomet\/6.1.1","article-title":"The probable error of a mean","volume":"6","author":"Student","year":"1908","journal-title":"Biometrika"},{"issue":"4","key":"10.1002\/14651858.CD001511.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0168-8278(00)80219-6","article-title":"Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids","volume":"32","author":"Ta\u00efeb","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0143|cit143","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0144|cit144","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0145|cit145","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0149|cit149","unstructured":"World Health Organization Global strategy to reduce the harmful use of alcohol www.who.int\/substance_abuse\/msbalcstragegy.pdf"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0150|cit150","unstructured":"Sauced RS Update on Background Paper 6.14. Harmful use of alcohol, alcohol use, disorders, and alcoholic liver diseases www.who.int\/medicines\/areas\/priority_medicines\/BP6_14Alcohol.pdf"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD001511.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"67-76","DOI":"10.1111\/j.1530-0277.1999.tb04025.x","article-title":"Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1","volume":"23","author":"Wu","year":"1999","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"6","key":"10.1002\/14651858.CD001511.pub3-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001511.pub2","article-title":"Glucocorticosteroids for people with alcoholic hepatitis","author":"Pavlov","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001511.pub3-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001511","article-title":"Glucocorticosteroids for alcoholic hepatitis","author":"Saconato","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001511.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001511.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:03:47Z","timestamp":1628543027000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001511.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":154,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001511.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001511.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]}}}